Skip to search formSkip to main contentSkip to account menu

cyclophosphamide/doxorubicin/tirapazamine

Known as: CTX/DOX/SR-4233 
National Institutes of Health

Related topics

Related topics

4 relations
CyclophosphamideDoxorubicinDoxorubicin Hydrochloridetirapazamine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Hypoxic cell sensitization in chemoradiation for cervical cancer
The integration of cisplatin into radiation regimens was first developed in locally advanced cervical cancer, a tumour where… 
1992
1992
The effect of the hypoxic cell drug SR-4233 alone or combined with the ionizing radiations on two human tumor cell lines having different radiosensitivity.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)